⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PCSA News
Processa Pharmaceuticals, Inc. Common
Form 8-K
sec.gov
PCSA
Processa Pharmaceuticals Announces Corporate and Pipeline Progress Following Acquisition of Vidya Therapeutics
globenewswire.com
PCSA
Form 8-K/A
sec.gov
PCSA
Processa Pharmaceuticals to Participate in Upcoming Investor Conferences
globenewswire.com
PCSA
Form 8-K
sec.gov
PCSA
Form 8-K
sec.gov
PCSA
PROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. AND APPROXIMATELY $200 MILLION CONCURRENT PRIVATE PLACEMENT TO ADVANCE BTK INHIBITOR, VT-7208, IN MULTIPLE DISEASE AREAS
globenewswire.com
PCSA
Form 8-K
sec.gov
PCSA
Form 8-K
sec.gov
PCSA
Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
PCSA